1. Essential Oil Composition of Alluaudia procera and in Vitro Biological Activity on Two Drug-Resistant Models
   null Poma et al, 2019, Molecules CrossRef
2. Targeting Pharmacokinetic Drug Resistance in Acute Myeloid Leukemia Cells with CDK4/6 Inhibitors
   Ales Sorf et al, 2020, Cancers CrossRef
3. Superior Pyrimidine Derivatives as Selective ABCG2 Inhibitors and Broad-Spectrum ABCB1, ABCC1, and ABCG2 Antagonists
   Katja Silbermann et al, 2020, J. Med. Chem. CrossRef
4. C@PA: Computer-Aided Pattern Analysis to Predict Multitarget ABC Transporter Inhibitors
   Vigneshwaran Namasivayam et al, 2021, J. Med. Chem. CrossRef
5. VLA-4 Induces Chemoresistance of T Cell Acute Lymphoblastic Leukemia Cells via PYK2-Mediated Drug Efflux
   Sofiane Berrazouane et al, 2021, Cancers CrossRef
6. The human ATP‐binding cassette (ABC) transporter superfamily
   Michael Dean et al, 2022, Human Mutation CrossRef
7. Isocitrate dehydrogenase 2 inhibitor enasidenib synergizes daunorubicin cytotoxicity by targeting aldo-keto reductase 1C3 and ATP-binding cassette transporters
   Anselm Morell et al, 2022, Arch Toxicol CrossRef
8. The influence of BCL2, BAX, and ABCB1 gene expression on prognosis of adult de novo acute myeloid leukemia with normal karyotype patients
   Zlatko Pravdic et al, 2023 CrossRef
9. Acute myeloid leukemia in elderly patients: New targets, new therapies
   Hae J. Park et al, 2023, Aging and Cancer CrossRef
10. Up-regulation of ABCG1 is associated with methotrexate resistance in acute lymphoblastic leukemia cells
    Yao Chen et al, 2024, Front. Pharmacol. CrossRef